Keratinocytcancer

Emilie Westerlin Kjeldsen; Vinzent Kevin Ortner; Ann-Kathrine Rossau; Flemming Andersen; Gabrielle Vinding; Henrik Lorentzen; Henrik Sølvsten; Katrine Togsverd-Bo; Kristine Pallesen; Peter Bjerring; Trine  Høgsberg; Ulrikke Lei; Merete Haedersdal

doi:10.61409/V10240733

Keratinocytcancer

Emilie Westerlin Kjeldsen, Vinzent Kevin Ortner, Ann-Kathrine Rossau, Flemming Andersen, Gabrielle Vinding, Henrik Lorentzen, Henrik Sølvsten, Katrine Togsverd-Bo, Kristine Pallesen, Peter Bjerring, Trine Høgsberg, Ulrikke Lei, Merete Haedersdal^*

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

3 Downloads (Pure)

Abstract

Keratinocyte cancer (KC) cases have risen by 172% in Denmark over the last decade and the lifetime risk of developing KC is at least 22%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.

Bidragets oversatte titel	Keratinocyte cancer
Originalsprog	Dansk
Artikelnummer	V10240733
Tidsskrift	Ugeskrift for Læger
Vol/bind	187
Udgave nummer	7A
ISSN	0041-5782
DOI	https://doi.org/10.61409/V10240733
Status	Udgivet - 31. mar. 2025

Emneord

Carcinoma, Basal Cell/epidemiology
Denmark/epidemiology
Humans
Incidence
Keratinocytes/pathology
Keratoconus/epidemiology
Registries
Risk
Skin Neoplasms/epidemiology

Dokumenter og links

10.61409/V10240733Licens: CC BY-NC-ND

Open Access VersionForlagets udgivne version, 1,24 MBLicens: CC BY-NC-ND

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{99847ce62b564fa7b8571c0f23ad63c4,

title = "Keratinocytcancer",

abstract = "Keratinocyte cancer (KC) cases have risen by 172\% in Denmark over the last decade and the lifetime risk of developing KC is at least 22\%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.",

keywords = "Carcinoma, Basal Cell/epidemiology, Denmark/epidemiology, Humans, Incidence, Keratinocytes/pathology, Keratoconus/epidemiology, Registries, Risk, Skin Neoplasms/epidemiology",

author = "Kjeldsen, \{Emilie Westerlin\} and Ortner, \{Vinzent Kevin\} and Ann-Kathrine Rossau and Flemming Andersen and Gabrielle Vinding and Henrik Lorentzen and Henrik S{\o}lvsten and Katrine Togsverd-Bo and Kristine Pallesen and Peter Bjerring and Trine H{\o}gsberg and Ulrikke Lei and Merete Haedersdal",

year = "2025",

month = mar,

day = "31",

doi = "10.61409/V10240733",

language = "Dansk",

volume = "187",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "L{\ae}geforeningen",

number = "7A",

}

TY - JOUR

T1 - Keratinocytcancer

AU - Kjeldsen, Emilie Westerlin

AU - Ortner, Vinzent Kevin

AU - Rossau, Ann-Kathrine

AU - Andersen, Flemming

AU - Vinding, Gabrielle

AU - Lorentzen, Henrik

AU - Sølvsten, Henrik

AU - Togsverd-Bo, Katrine

AU - Pallesen, Kristine

AU - Bjerring, Peter

AU - Høgsberg, Trine

AU - Lei, Ulrikke

AU - Haedersdal, Merete

PY - 2025/3/31

Y1 - 2025/3/31

N2 - Keratinocyte cancer (KC) cases have risen by 172% in Denmark over the last decade and the lifetime risk of developing KC is at least 22%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.

AB - Keratinocyte cancer (KC) cases have risen by 172% in Denmark over the last decade and the lifetime risk of developing KC is at least 22%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.

KW - Carcinoma, Basal Cell/epidemiology

KW - Denmark/epidemiology

KW - Humans

KW - Incidence

KW - Keratinocytes/pathology

KW - Keratoconus/epidemiology

KW - Registries

KW - Risk

KW - Skin Neoplasms/epidemiology

U2 - 10.61409/V10240733

DO - 10.61409/V10240733

M3 - Tidsskriftartikel

C2 - 40171911

SN - 0041-5782

VL - 187

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 7A

M1 - V10240733

ER -

Keratinocytcancer

Abstract

Emneord

Dokumenter og links

SDU link

Fingeraftryk

Citationsformater